Zydus Lifesciences reports 27% rise in Q3 consolidated net profit

09 Feb 2024 Evaluate

Zydus Lifesciences has reported results for third quarter ended December 31, 2023 (Q3FY24).

The company has reported 76.01% rise in its net profit at Rs 450.40 crore for Q3FY24 as compared to Rs 255.90 crore for the same quarter in the previous year. Total income of the company increased by 15.30% at Rs 2478.10 crore for Q3FY24 as compared Rs 2149.30 crore for corresponding quarter of the previous year. 

On consolidated basis, the company has reported 26.76% rise in net profit at Rs 789.60 crore for the third quarter ended December 31, 2023 as compared to Rs 622.90 crore for the same quarter in the previous year. Total income of the company increased by 5.76% at Rs 4542.90 crore for Q3FY24 as compared Rs 4295.60 crore for corresponding quarter of the previous year.

Zydus Lifesciences Share Price

988.00 0.00 (0.00%)
02-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.00
Dr. Reddys Lab 6260.00
Cipla 1419.55
Zydus Lifesciences 988.00
Lupin 1647.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.